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Background: Oral mucositis is one of the common complications of cancer chemotherapy and about 40% of the
patients who take chemotherapy protocols, experience this irritating problem. The purpose of this study was to
draw comparison between the therapeutic effects of our treatment modalities (topical steroid, honey, honey plus
coffee) in patients suffering from oral mucositis.
Methods: This was a double blinded randomised clinical trial of a total of 75 eligible adult participants which they
randomly fell into three treatment groups. For all the participants a syrup-like solution was prepared. Each 600 grams of
the product consisted of “20 eight-mg Betamethasone solution ampoules” in the Steroid (S) group, “300 grams of honey
plus 20 grams of instant coffee” in the Honey plus Coffee (HC) group, and “300 grams of honey” for the Honey (H) group.
The participants were told to sip 10 ml of the prescribed product, and then swallow it every three hours for one week.
Severity of lesions was clinically evaluated before the treatment and also one week after the initiation of the intervention.
This study adhered to the principles of the Declaration of Helsinki and guidelines of Good Clinical Practice.
Results: This study showed that all three treatment regimens reduce the severity of lesions. The best reduction in
severity was achieved in HC group. H group and S group took the second and third places. In other words, honey plus
coffee regimen was the most effective modality for the treatment of oral mucositis.
Conclusion: Oral mucositis can be successfully treated by a combination of honey and coffee as an alternative medicine
in a short time. Further investigations are warranted in this field.
Trial registration: Iranian Registry of Clinical Trials IRCT: 201104074737N3, (9 May 2011).
Keywords: Oral mucositis, Cancer chemotherapy, Honey, Coffee, Topical steroidBackground
Approximately 57 million deaths occur every year in the
world which cancers are responsible for 27% of them
[1,2]. Increased life expectancy, environmental alterations,
the changes in lifestyle, potential precise diagnosis, longer
life spans and smoking are some of the mentioned causes
for increased cancer rates [3,4].
Cancers are mostly treated with one or more cytotoxic
anti-neoplastic agents (chemotherapeutic drugs) as part of
a standardised regimen [5]. Anti-neoplastic or cytotoxic* Correspondence: raeessi_neda@yahoo.com
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unless otherwise stated.drugs trigger all cells with rapid replication cycle. Thereby
not only they kill cancer cells, but also hair follicles, bone
marrow cells and basal epithelial cells of digestive
tract are implicated. Therefore the patients who receive
chemotherapy drugs may suffer from mucositis in oral
cavity, oropharynx and digestive system [6]. Oral
mucositis is one of the common irritating complications
of cancer treatment [7,8]. At least 30-40% of the patients
who take chemotherapy drugs, experience some degrees
of this oral problem which starts five to ten days after the
initiation of the treatment regimen [6].
Oral mucositis is characterised by inflammation,
erythema and ulcerations of the mucous membrane of
the oral cavity. This mucositis cusses a lot of pain whichLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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complications such as dehydration, parageusia and
malnutrition. In myelosuppressed cancer patients, the
infected mucous of the oral cavity can also be a source of
systemic infection and septicemia [9]. Undoubtedly, its
effective therapy can substantially reduce the oral
complications and the risk of oral and systemic infections.
One of the common treatments for oral mucositis is
topical steroids which is expensive and may have side
effects [10-14]. Our suggested treatment is the combination
of coffee and honey.
Honey is one of the oldest known natural drugs and
since ancient times has been regarded as a health giving
substance [15]. Its medical use is recorded from around
3000 B.C. onward and is addressed as a curative substance
in the holy Bible. Honey has been highly valued in the
Middle East region and it was mentioned as a curative
material for human illnesses more than 1400 years ago in
the Holy Quran. In traditional medicine, honey has been
used for treatment of the signs and symptoms of Upper
Respiratory Tract Infections (URTIs), especially coughing
[16-20]. The World Health Organization (WHO) has cited
that honey demulcents may soothe the throat and
therefore it can be a potential treatment for cough
and other URTI symptoms [17].
Honey bees produce honey from flower nectar [21,22].
Since honey is not a generic product and its ingredients
and their relative amounts depend on the flora of the
area from which honey bees collect pollen, it is difficult
to determine the composition of honey [23]. It has been
reported that honey contains more than 200 substances
such as sugars, proteins, minerals, some vitamins, organic
acids and antioxidants (phenolic compounds, enzymes,
flavonoids, amino acids, carotenoid-like substances and
other phytochemicals) [22,24-26]. According to some
studies, honey by its antioxidants can increase cytokine
release and has antimicrobial effects [27-29]. Moreover it
can prevent cellular oxidative damage which leads to
aging, diseases and death [22].
In recent decades, honey has been rediscovered for the
maintenance of health in several diseases, burns, injuries,
and wounds [17,30]. It has many medicinal properties
including its wound healing capacity [31]. Moreover,
honey reduces inflammation and edema, stimulates
epithelialisation and tissue regeneration and thus improves
granulation and debridement [16,32,33] which in turn
accelerates tissue repair and leads to wound healing
[16,20,32-36]. Owing to its therapeutic properties in the
treatment of gingivitis and periodontal disorders, honey is
also recommended for dental hygiene [37,38]. Honey by its
sweet substances stimulates saliva secretion and also the
secretion of mucus in the airways [16,32,39]. Previously,
some studies have proved promising effects of honey on
the cancer treatment-induced oral mucositis [9,40-42].On the other hand, Caffeine is a natural alkaloid in
coffee, tea, cola drinks, and cocoa [43]. Bronchodilators
such as methylxanthines (theophylline and caffeine)
stimulate breathing and have been used to prevent apnea
[43,44]. Caffeine is also hypoalgesic and has anti-oxidant
and anti-inflammatory effects [43-45]. It is the world’s most
commonly used psychoactive substance which stimulates
the central nervous system [46]. Caffeine improves
psychomotor performance and increases self-reported
alertness and decreases self-reported weariness and
sleepiness. Coffee per se or its specific compounds contain
antioxidant properties and have protective effects against
oxidative DNA damage, liver lesions (hepatotoxicant
induced fibrosis) and tissue damage [47]. Coffee consump-
tion also attenuates liver induced insulin resistance [48].
To the best of our knowledge, there have been no previ-
ous reports about the combination of honey and coffee as
a treatment for oral mucositis. While assessing the effect
of “honey plus coffee” on the persistence post-infectious
cough in our three previous studies [49-51], we noticed
the rapid healing impact of this treatment modality on the
lesions in hypopharynx mucosal membrane. Thus we
decided to design a new trial to evaluate the effect of this
regimen on oral mucositis after cancer chemotherapy.
Considering the great number of people around the world
suffering from oral mucositis, the aim of this study was to
evaluate the therapeutic effects of coffee plus honey and
compare them with those of topical steroids in the treatment
of patients with oral mucositis after cancer chemotherapy.Methods
Design and setting
We have conducted a double-blind randomised clinical
trial of 75 adult participants (39 women) presenting oral
mucositis after chemotherapy during a period of three
years at Baqiyatallah University Hospital, Tehran, Iran
from 2011 to 2013.Participants
Assuming alpha and beta errors of 5% and 20% respectively,
and considering the results significant if the severity of
disease changed more than 25% of the mean, we calculated
the sample size by its formula: 21 persons for each
treatment group. The patients were registered in our
clinic after completion of a check list of their personal
characteristics including sex, age, weight, education,
occupation, and the presence of any other systemic
diseases. All the participants provided a comprehensive
history and underwent a physical examination of the mouth
and throat for any abnormalities. In addition, routine
laboratory tests were carried out. Patients with oral mucosi-
tis after chemotherapy, and with the age range between 15
and 80 years, were included in the study. Patients with
Table 1 Characteristics of participants in the three








Male 11 (52.4) 9 (42.9) 10 (50.0)
Female 10 (47.6) 12 (57.1) 10 (50.0)
Level of schooling:
Primary & Diploma 17 (81.0) 20 (95.2) 15 (75.0)
Higher education 4 (19.0) 1 (4.8) 5 (25.0)
Occupation:
Housewife 6 (28.6) 12 (57.1) 6 (30.0)
Employed 2 (9.5) 3 (14.3) 1 (5.0)
Retired 3 (14.3) 3 (14.3) 4 (20.0)
Unemployed 10 (47.6) 3 (13.6) 9 (45.0)
S = Steroid; HC = Honey plus Coffee; H = Honey.
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tests were excluded.
Ethical considerations
The volunteer participants were informed about the aim
and the potential benefits of the study, the prescribed
regimens, the follow-up sessions, and their own duty.
We informed them about the potential complications
including dyspepsia and insomnia, and how to confront
them. Informed consent was taken from them before the
enrollment in the study. The data and the files have been
kept confidential. This prospective trial and its design
were approved by the Ethics Committee of Baqiyatallah
University of Medical Sciences. The study adheres to the
principles of the Declaration of Helsinki and guidelines
of Good Clinical Practice. We have registered this
clinical trial in the Iranian Registry of Clinical Trials
IRCT: 201104074737N3, (9 May 2011).
Intervention
We utilised online statistical computing web programming
(www.graphpad.com) to generate the randomisation
schedule. Therefore, all the 75 included participants
were randomly distributed into three groups and three
regimens of medical syrup-like solution were prepared,
as follows:
1. Each 600 g of the first regimen consisted of 20
ampoules of Betamethasone (each contained eight
mg of Betamethasone solution), given to every
member of the Steroid (S) group.
2. Each 600 g of the second regimen consisted of 300 g
of honey and 20 g of original instant coffee given to
every member of the Honey plus Coffee (HC) group.
3. Each 600 g of the third regimen contained only
300 g of honey as a supportive treatment given to
every member of the Honey (H) group.
All the products were in same colour, shape, and taste
(by adding enough coffee essence, edible brown colour
and artificial honey flavour) and also they had similar
packages. The amounts of the ingredients were determined
in accordance with usual daily usage. The ingredients were
gently mixed and homogenised. We obtained the natural
honey from the Zagros Mountains in the west of Iran and
also used original instant coffee by Nestle Spain Ltd. The
study products should be stored at room temperature of
about 22–26°C.
The samples were produced by our pharmacists.
We determined the sample sizes using a randomised
program and then encoded the samples confidentially
and distributed them randomly between the participants.
The participants were told to sip three teaspoonfuls
(about ten mL) of the prescribed product, and thenswallow it. They were asked to repeat it every three hours
for one week. The participants were unaware of their own
regimen and agreed not to use any additional anti-
inflammatory agents, even honey or coffee. In addition,
the study investigators were unaware of the prescribed
regimen and did not participate as patients in the study.
Main outcome measures
In all participants the severity of their oral mucositis was
clinically evaluated before the treatment and also one week
after initiation of the intervention and thereby the check-
lists were completed. Five experts in the field accepted the
validity of our designed questionnaire. With regard to
reliability, the questionnaire had a 0.87 of Cronbach’s alpha
coefficient. Using a visual analogue score, physicians filled
in the questionnaires according to patients’ answers and the
participants were then categorised on the basis of the
WHO Oral Toxicity Scale for grading oral mucositis. This
scale combines both objective (mucosal changes such as
redness and ulceration) and functional (inability to eat)
outcomes into a single score [52]. Thus the severity of
illness was graded as: no oral mucositis (0), mild (1+),
moderate (2+), and severe (3+) conditions.
Statistical analysis
The statistical analyses were carried out using SPSS 16.0
software (SPSS Inc. Chicago, IL). Continuous variables
were presented as mean and standard deviation (STD)
and categorical variables were presented as absolute
and relative frequencies. One-way ANOVA, Chi-square
test, Wilcoxon signed ranks test, paired t test and post
hoc (Tukey) tests were used to compare the groups. All
reported p values were based on two-sided hypotheses.
The distribution of the baseline characteristics are shown
in Table 1.
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For each group, the numbers of participants who were
randomly enrolled, received intended treatment and
were analysed along with the losses and exclusions are
depicted in the flow diagram (Figure 1). In this clinical
trial the mean (STD) of age and weight were 55.2 (13.2)
years, and 77.4 (10.4) kgs respectively. Also the mean (STD)
of the severity of illness was 2.57 (0.49) pre-treatment and
0.90 (0.76) post-treatment (Table 2). One-way analysis of
variances and Wilcoxon signed rank test, showed that the
differences between variables including age and severity of
illness before treatment in all three groups were the same
and were not statistically significant (p > 0.05, Table 2). The
Chi-square test showed that the distribution of variables
including sex and education levels were the same in the
three groups (p > 0.05).
The paired t test and post hoc (Tukey) tests showed
that the changes in the mean of the severity of illnessAssessed fo
Analysed (n=21)
Excluded from analysis (n=0)
Lost to follow-up (n=2) 
discontinued intervention (n=2)
Allocated to intervention 1 (HC group)
(n=23)
Received allocated intervention (n=23)














Figure 1 The flow diagram of the study.before and after treatment with every three regimens
were statistically significant (p < 0.05). It conveys that
generally all three treatment regimens were effective
(Table 2), while the mean of changes in severity of illness
in the “HC group” was higher than other two groups. To
put in a nutshell, the results of this study showed that
the honey plus coffee regimen had prominently more
curative effect on severity of illness.
Discussion
Oral mucositis is reported to account for 30–40% of all
cases of cancer chemotherapy [6]. The goal of this trial
was to evaluate and compare the therapeutic impact of
honey plus coffee with topical steroid in patients with
oral mucositis after cancer chemotherapy. The results
showed that the combination of honey and coffee is a
better treatment modality for oral mucositis compared with
topical steroid. Eliminating the unpleasant consequences ofr eligibility (n=96)
Excluded (n=21)
Not meeting inclusion criteria (n=15)
Declined to participate (n=3)
Other reasons (n=3)
Lost to follow-up (n=3) 
discontinued intervention (n=2)
Allocated to intervention 3 (C group)
(n=23)
Received allocated intervention (n=21)













Excluded from analysis (n=0)
Table 2 Mean (STD) of differences between treatments and some explanatory variables
Variables S group HC group H group P-value
Age (years) (STD) 55.9 (12.7) 54.7 (15.4) 54.9 (11.6) 0.948 (NS)*
Weight (Kgs) (STD) 80.3 (9.2) 73.4 (10.9) 78.4 (10.5) 0.090 (NS)*
Mean severity of illness (degree) (STD):
a- before the treatment 2.52 (0.51) 2.67 (0.48) 2.50 (0.51) 0.517 (NS)*
b- after the treatment 1.43 (0.75) 0.38 (0.50) 0.90 (0.65) < 0.001(S)**
*NS = Not Significant; **S = Significant; STD = Standard Deviation; S = Steroid; H = Honey; HC = Honey plus Coffee.
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effective. Honey and coffee are natural edible substances
that are agreeable, safe, rather reasonable and easily avail-
able. In addition they have proved to be effective in a short
period of time. While assessing the effect of “honey plus
coffee” on the persistent post-infectious cough in our pre-
vious studies [49-51], we noticed the rapid healing impact
of this treatment modality on the lesions in hypopharynx
mucosal membrane. Thus we decided to design a new trial
to evaluate the effect of this regimen on oral mucositis
after cancer chemotherapy. In this trial we suggested that
the patients take small mouthfuls of the solution, sip
and then swallow them. Applying this instruction, our
medicinal solution would help healing not only oral
cavity lesions, but also any mucosal inflammation in
the oropharynx, hypopharynx and esophagus. This is
one of the advantages of our suggested treatment
regimen.
Although the exact mechanism of action of “honey” is
not definitely known, osmolality, acidity, and the
production of hydrogen peroxide have been proposed to
be the main factors [20]. By reducing prostaglandin
synthesis at the site of application, honey lowers
plasma prostaglandin concentrations [29]. It also has
antioxidant and anti-inflammatory efficacies and increases
nitric oxide (NO) in the lesions [29]. It is proposed that,
sweet substances per se stimulate the salivation reflex due
to their hyperosmolarity. The effects of honey may be
related to its hyperosmolarity, anti-inflammatory and
antioxidant properties [9,17,53-55]. As a result of all
these properties, honey can accelerate the repair and
healing of mucosal desquamation and thus reduce
mucosal irritation [16,17,30,32,39,53,55].
We have chosen the combination of honey and coffee
because they are both mentioned in complementary
medicine and their mixture is safe and acceptable. It
has been reported that honey or coffee separately
have treatment impact on some of the respiratory diseases
and honey can stimulate mucosal tissue healing in oral
mucositis, but to the best of our knowledge, there are no
reports in the literature on the combination of these two
for oral mucositis. Only our three previous trials showed
that “honey plus coffee” regimen is the most effective
treatment modality for the Persistent Post-infectiousCough, and also those studies proved that the combin-
ation has a greater effect compared with each product
separately [49-51].
Yet, it has not been explained how the “combination
of honey and coffee” acts, but the impact may be due to
the synergistic effect of these two substances. Repairing
mucosal desquamation and mucosal irritability, this com-
bination can bring about considerable improvements in
mucosal tissue healing.
Interesting finding
The previous scientific information about caffeine
shows it is a psychoactive and hypoalgesic substance,
it stimulates breathing and dilates the bronchi and
has anti-oxidant/anti-inflammatory effects which protect
liver and other tissues [43-47]. Moreover, it reduces liver
induced insulin resistance [48]. But with the present study
and our other three recent studies we have found a new
property for caffeine in combination with honey: “It can
speed up wound healing” [49-51].
Further investigations with larger sample sizes are
required to make the results more reliable.
Conclusion
Oral mucositis may be successfully treated by the
“combination of honey and coffee” in a short time.
Compared with topical steroid, this treatment modality can
be used as an alternative medicine in the treatment
of oral mucositis. We therefore recommend the use of this
effective treatment modality for patients with oral
mucositis. Further investigations are warranted.
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